Resolution of the National Multidisciplinary Research Council of Experts on the place of anti-interleukin-6 receptor monoclonal antibodies (Sarilumab) in the treatment of patients with rheumatoid arthritis and comorbidity

.

Bibliographic Details
Main Author: article Editorial
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2020-06-01
Series:Научно-практическая ревматология
Online Access:https://rsp.mediar-press.net/rsp/article/view/2905
id doaj-b5485ddc8d624168bd9af4d167451cae
record_format Article
spelling doaj-b5485ddc8d624168bd9af4d167451cae2021-08-02T09:05:54ZrusIMA-PRESS LLCНаучно-практическая ревматология1995-44841995-44922020-06-015832625Resolution of the National Multidisciplinary Research Council of Experts on the place of anti-interleukin-6 receptor monoclonal antibodies (Sarilumab) in the treatment of patients with rheumatoid arthritis and comorbidityarticle Editorial.https://rsp.mediar-press.net/rsp/article/view/2905
collection DOAJ
language Russian
format Article
sources DOAJ
author article Editorial
spellingShingle article Editorial
Resolution of the National Multidisciplinary Research Council of Experts on the place of anti-interleukin-6 receptor monoclonal antibodies (Sarilumab) in the treatment of patients with rheumatoid arthritis and comorbidity
Научно-практическая ревматология
author_facet article Editorial
author_sort article Editorial
title Resolution of the National Multidisciplinary Research Council of Experts on the place of anti-interleukin-6 receptor monoclonal antibodies (Sarilumab) in the treatment of patients with rheumatoid arthritis and comorbidity
title_short Resolution of the National Multidisciplinary Research Council of Experts on the place of anti-interleukin-6 receptor monoclonal antibodies (Sarilumab) in the treatment of patients with rheumatoid arthritis and comorbidity
title_full Resolution of the National Multidisciplinary Research Council of Experts on the place of anti-interleukin-6 receptor monoclonal antibodies (Sarilumab) in the treatment of patients with rheumatoid arthritis and comorbidity
title_fullStr Resolution of the National Multidisciplinary Research Council of Experts on the place of anti-interleukin-6 receptor monoclonal antibodies (Sarilumab) in the treatment of patients with rheumatoid arthritis and comorbidity
title_full_unstemmed Resolution of the National Multidisciplinary Research Council of Experts on the place of anti-interleukin-6 receptor monoclonal antibodies (Sarilumab) in the treatment of patients with rheumatoid arthritis and comorbidity
title_sort resolution of the national multidisciplinary research council of experts on the place of anti-interleukin-6 receptor monoclonal antibodies (sarilumab) in the treatment of patients with rheumatoid arthritis and comorbidity
publisher IMA-PRESS LLC
series Научно-практическая ревматология
issn 1995-4484
1995-4492
publishDate 2020-06-01
description .
url https://rsp.mediar-press.net/rsp/article/view/2905
work_keys_str_mv AT articleeditorial resolutionofthenationalmultidisciplinaryresearchcouncilofexpertsontheplaceofantiinterleukin6receptormonoclonalantibodiessarilumabinthetreatmentofpatientswithrheumatoidarthritisandcomorbidity
_version_ 1721235555798220800